These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 38197895)

  • 21. Impact of gender on heart failure presentation in non-obstructive hypertrophic cardiomyopathy.
    Jang JH; Shin SH; Beak YS; Ko KY; Kwon SW; Park SD; Woo SI; Kim DH; Kwan J
    Heart Vessels; 2020 Feb; 35(2):214-222. PubMed ID: 31482215
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of digoxin in patients with heart failure and mid-range (borderline) left ventricular ejection fraction.
    Abdul-Rahim AH; Shen L; Rush CJ; Jhund PS; Lees KR; McMurray JJV;
    Eur J Heart Fail; 2018 Jul; 20(7):1139-1145. PubMed ID: 29493058
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical characteristics, one-year change in ejection fraction and long-term outcomes in patients with heart failure with mid-range ejection fraction: a multicentre prospective observational study in Catalonia (Spain).
    Farré N; Lupon J; Roig E; Gonzalez-Costello J; Vila J; Perez S; de Antonio M; Solé-González E; Sánchez-Enrique C; Moliner P; Ruiz S; Enjuanes C; Mirabet S; Bayés-Genís A; Comin-Colet J;
    BMJ Open; 2017 Dec; 7(12):e018719. PubMed ID: 29273666
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Echocardiographic Features of Patients With Heart Failure and Preserved Left Ventricular Ejection Fraction.
    Shah AM; Cikes M; Prasad N; Li G; Getchevski S; Claggett B; Rizkala A; Lukashevich I; O'Meara E; Ryan JJ; Shah SJ; Mullens W; Zile MR; Lam CSP; McMurray JJV; Solomon SD;
    J Am Coll Cardiol; 2019 Dec; 74(23):2858-2873. PubMed ID: 31806129
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictors and prognostic implications of left ventricular ejection fraction trajectory improvement in the spectrum of heart failure with reduced and mildly reduced ejection fraction.
    Si J; Ding Z; Hu Y; Zhang X; Zhang Y; Cao H; Liu Y
    J Cardiol; 2024 Apr; 83(4):250-257. PubMed ID: 37802201
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acute heart failure with mid-range left ventricular ejection fraction: clinical profile, in-hospital management, and short-term outcome.
    Farmakis D; Simitsis P; Bistola V; Triposkiadis F; Ikonomidis I; Katsanos S; Bakosis G; Hatziagelaki E; Lekakis J; Mebazaa A; Parissis J
    Clin Res Cardiol; 2017 May; 106(5):359-368. PubMed ID: 27999929
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recurrent hospitalizations are associated with increased mortality across the ejection fraction range in heart failure.
    Huusko J; Tuominen S; Studer R; Corda S; Proudfoot C; Lassenius M; Ukkonen H
    ESC Heart Fail; 2020 Oct; 7(5):2406-2417. PubMed ID: 32667143
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence and prognostic impact of non-cardiac co-morbidities in heart failure outpatients with preserved and reduced ejection fraction: a community-based study.
    Iorio A; Senni M; Barbati G; Greene SJ; Poli S; Zambon E; Di Nora C; Cioffi G; Tarantini L; Gavazzi A; Sinagra G; Di Lenarda A
    Eur J Heart Fail; 2018 Sep; 20(9):1257-1266. PubMed ID: 29917301
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic significance of cardiac I-123-metaiodobenzylguanidine imaging in patients with reduced, mid-range, and preserved left ventricular ejection fraction admitted for acute decompensated heart failure: a prospective study in Osaka Prefectural Acute Heart Failure Registry (OPAR).
    Seo M; Yamada T; Tamaki S; Watanabe T; Morita T; Furukawa Y; Kawasaki M; Kikuchi A; Kawai T; Abe M; Nakamura J; Yamamoto K; Kayama K; Kawahira M; Tanabe K; Kimura T; Ueda K; Sakamoto D; Sakata Y; Fukunami M
    Eur Heart J Cardiovasc Imaging; 2021 Jan; 22(1):58-66. PubMed ID: 32091079
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardiovascular magnetic resonance predictors of heart failure in hypertrophic cardiomyopathy: the role of myocardial replacement fibrosis and the microcirculation.
    Raphael CE; Mitchell F; Kanaganayagam GS; Liew AC; Di Pietro E; Vieira MS; Kanapeckaite L; Newsome S; Gregson J; Owen R; Hsu LY; Vassiliou V; Cooper R; Mrcp AA; Ismail TF; Wong B; Sun K; Gatehouse P; Firmin D; Cook S; Frenneaux M; Arai A; O'Hanlon R; Pennell DJ; Prasad SK
    J Cardiovasc Magn Reson; 2021 Mar; 23(1):26. PubMed ID: 33685501
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of atrial fibrillation in patients with heart failure and reduced, mid-range or preserved ejection fraction.
    Son MK; Park JJ; Lim NK; Kim WH; Choi DJ
    Heart; 2020 Aug; 106(15):1160-1168. PubMed ID: 32341140
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic Value of Cardiopulmonary Exercise Testing in Heart Failure With Reduced, Midrange, and Preserved Ejection Fraction.
    Nadruz W; West E; Sengeløv M; Santos M; Groarke JD; Forman DE; Claggett B; Skali H; Shah AM
    J Am Heart Assoc; 2017 Oct; 6(11):. PubMed ID: 29089342
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impaired systolic function by strain imaging in heart failure with preserved ejection fraction.
    Kraigher-Krainer E; Shah AM; Gupta DK; Santos A; Claggett B; Pieske B; Zile MR; Voors AA; Lefkowitz MP; Packer M; McMurray JJ; Solomon SD;
    J Am Coll Cardiol; 2014 Feb; 63(5):447-56. PubMed ID: 24184245
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characteristics and long-term prognosis of patients with reduced, mid-range, and preserved ejection fraction: A systemic review and meta-analysis.
    Liang M; Bian B; Yang Q
    Clin Cardiol; 2022 Jan; 45(1):5-17. PubMed ID: 35043472
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Right ventricular function declines prior to left ventricular ejection fraction in hypertrophic cardiomyopathy.
    Mahmod M; Raman B; Chan K; Sivalokanathan S; Smillie RW; Samat AHA; Ariga R; Dass S; Ormondroyd E; Watkins H; Neubauer S
    J Cardiovasc Magn Reson; 2022 Jun; 24(1):36. PubMed ID: 35692049
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Contribution of cardiac and extra-cardiac disease burden to risk of cardiovascular outcomes varies by ejection fraction in heart failure.
    Wolsk E; Claggett B; Køber L; Pocock S; Yusuf S; Swedberg K; McMurray JJV; Granger CB; Pfeffer MA; Solomon SD
    Eur J Heart Fail; 2018 Mar; 20(3):504-510. PubMed ID: 29193462
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum uric acid and outcomes in patients with chronic heart failure through the whole spectrum of ejection fraction phenotypes: Analysis of the ESC-EORP Heart Failure Long-Term (HF LT) Registry.
    Ambrosio G; Leiro MGC; Lund LH; Coiro S; Cardona A; Filippatos G; Ferrari R; Piepoli MF; Coats AJS; Anker SD; Laroche C; Almenar-Bonet L; Poder P; Valero DB; Frisinghelli A; Maggioni AP
    Eur J Intern Med; 2021 Jul; 89():65-75. PubMed ID: 33896684
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mean platelet volume: a prognostic marker in heart failure with preserved ejection fraction.
    Menghoum N; Beauloye C; Lejeune S; Badii MC; Gruson D; van Dievoet MA; Pasquet A; Vancraeynest D; Gerber B; Bertrand L; Horman S; Pouleur AC
    Platelets; 2023 Dec; 34(1):2188965. PubMed ID: 37157842
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sudden cardiac arrest with shockable rhythm in patients with heart failure.
    Woolcott OO; Reinier K; Uy-Evanado A; Nichols GA; Stecker EC; Jui J; Chugh SS
    Heart Rhythm; 2020 Oct; 17(10):1672-1678. PubMed ID: 32504821
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Heart failure with preserved ejection fraction has a better long-term prognosis than heart failure with reduced ejection fraction in old patients in a 5-year follow-up retrospective study.
    Kontogeorgos S; Thunström E; Johansson MC; Fu M
    Int J Cardiol; 2017 Apr; 232():86-92. PubMed ID: 28100428
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.